Skip to main content

Table 3 Data Assessment Schedule

From: A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

Data assessment

Screening

Baseline

Week 0

Dose adjustment 1

Week 2

Dose adjustment 2

Week 4

Dose adjustment 3

Week 8

On treatment

Week 26

Last dose

Week 52

Follow-up

Week 64

hCG-stimulation test

x

       

Blood pressure

x

x

x

x

x

x

x

x

Blood samples

x

x

x

x

x

x

x

x

Waist circumference

 

x

   

x

x

x

DXA scan

 

x

   

x

x

x

Oral glucose tolerance test

 

x

   

x

x

x

Questionnaires

 

x

   

x

x

x

Anogenital distance

 

x

    

x

 

Randomization

 

x

      

On treatment

 

x

x

x

x

x

x

 

Dose adjustment

  

x

x

x

   

Evaluation of side effects

 

x

x

x

x

x

x

x